Cardiogenesis Corporation to Report Third Quarter 2009 Results on November 10th
October 29 2009 - 6:30AM
PR Newswire (US)
IRVINE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Cardiogenesis
Corporation (Pink Sheets: CGCP), announced that the company will
release results for its third quarter ended September 30, 2009
after market close on Tuesday, November 10, 2009. The company also
said that Executive Chairman Paul J. McCormick and Senior Vice
President and Chief Financial Officer William R. Abbott will host
an investor conference call that day at 5:00 p.m. Eastern time
(2:00 p.m. Pacific time) to review the company's financial results
and business outlook. The call is open to all interested investors
through a live audio web broadcast via the Internet at
http://www.cardiogenesis.com/ and will also be available by dialing
(866) 362-4666. The participant passcode is 90770475. The call will
be archived on the company's web site and will be available for
playback for seven days beginning shortly after the live webcast.
About Cardiogenesis Corporation Cardiogenesis is a medical device
company specializing in the treatment of cardiovascular disease and
is a leader in devices that stimulate cardiac angiogenesis. The
company's market leading Holmium:YAG laser system and disposable
fiber-optic accessories are used to perform a FDA-cleared surgical
procedure known as Transmyocardial Revascularization (TMR) to treat
patients suffering from angina. Surgical products and accessories
for the Cardiogenesis TMR procedure, which are marketed in the U.S.
and around the world, have been shown to reduce angina and improve
the quality of life in patients with coronary artery disease. For
more information on the company and its products, please visit the
Cardiogenesis company website at http://www.cardiogenesis.com/ or
the direct to patient website at http://www.heartofnewlife.com/.
Cardiogenesis Corporation, +1-949-420-1800
http://www.cardiogenesis.com/ DATASOURCE: Cardiogenesis Corporation
CONTACT: William R. Abbott, Senior Vice President and Chief
Financial Officer of Cardiogenesis Corporation, +1-949-420-1800 Web
Site: http://www.cardiogenesis.com/ http://www.heartofnewlife.com/
Copyright